New executive industry perspectives overheard at our Health Innovation Summit, Asia Edition.

And Other Key Takeaways from #OWHIC, Asia Edition

Asia has been quick to experiment in innovative customer journeys. But, patients are impatient.

Principal, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Asian healthcare is undergoing major disruption, and a new healthcare environment is emerging.

Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

The future of Indonesian healthcare is about a different kind of patient journey.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman
Partner, Head of Indonesia
Manager, Health & Life Sciences, Oliver Wyman
Consultant

Status quo disruption means blurring the lines between traditional and non-traditional models.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

We talk UK healthcare tech advancements and cracking brain cancer globally.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

We offset the carbon impact of our attendees' business flights at this year's Oliver Wyman Health Innovation Summit.

Edelman's solution-based advice on regaining trust in healthcare and how it got lost in the first place.

Chief Strategist, Health Practice, Edelman
Vice President, Global Sector Development, Health, Edelman

The Middle East is working to redefine its healthcare system amidst governmental regulation. Here are four key trends for a market on the leading edge of innovation.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Partners Sam Glick and Sven-Olaf Vathje write in Harvard Business Review on how countries around the world can learn from a broken American healthcare system.

Global Leader, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe
Load More